![](/img/cover-not-exists.png)
Increased multimodality treatment options has improved survival for Hepatocellular carcinoma but poor survival for biliary tract cancers remains unchanged
Alabraba, E., Joshi, H., Bird, N., Griffin, R., Sturgess, R., Stern, N., Sieberhagen, C., Cross, T., Camenzuli, A., Davis, R., Evans, J., O'Grady, E., Palmer, D., Diaz-Nieto, R., Fenwick, S., Poston,Journal:
European Journal of Surgical Oncology
DOI:
10.1016/j.ejso.2019.04.002
Date:
April, 2019
File:
PDF, 1.58 MB
2019